Art Levinson

Art Levinson is a highly influential figure in the American business and biotechnology sectors, renowned for his leadership and pioneering contributions. As the former CEO of Genentech and current chairman of Apple Inc., Levinson has left an indelible mark on both industries.

Levinson's career began at Genentech in 1980, where he played a pivotal role in advancing the company's capabilities in biotechnology and pharmaceuticals. Under his leadership, Genentech became a powerhouse in the development of innovative therapies for serious medical conditions, ranging from cancer to autoimmune disorders. His tenure at Genentech, marked by a commitment to scientific excellence and patient-centric innovation, solidified his reputation as a visionary leader in biotechnology.

In addition to his role at Genentech, Levinson has served as the chairman of Apple Inc. since 2011, guiding the tech giant through periods of significant innovation and growth. His strategic oversight has been instrumental in Apple's expansion into new markets and the development of groundbreaking products and services.

Beyond his corporate achievements, Levinson is known for his philanthropic endeavors. He is actively involved in supporting scientific research and education, particularly in the fields of biomedicine and technology. His contributions aim to foster innovation and improve healthcare outcomes globally.

Art Levinson's influence extends beyond his professional accomplishments. He is recognized for his advocacy on healthcare policy and his efforts to promote diversity and inclusion within the corporate world. Levinson's leadership continues to inspire and shape both the biotechnology and technology sectors in the United States and beyond.